Key result
Surgical treatment of benign cardiac tumors was successful with no relapses, while malignant tumors had a poor prognosis with an overall mortality of 27% over a median 44 months.
Why the study?
Cardiac tumors are rare, heterogeneous, and remain a diagnostic and therapeutic challenge, prompting an overview of surgical results over nearly 20 years at a tertiary care center.
Population
55 consecutive patients with a diagnosis of cardiac tumor undergoing surgical treatment
Comparison
Surgical treatment across benign and malignant cardiac tumor types
Design
Single center retrospective cohort study
Follow-up
Median 44 months
Authors
Loading...
Retrospective series supports surgical feasibility in rare cardiac tumors; leaves open need for prospective multicenter data to guide practice.
Observational (n=55)
No
Surgical resection of benign cardiac tumors yields excellent long-term outcomes with no relapses, whereas malignant cardiac tumors carry a poor prognosis despite radical surgery.
Restivo et al. (2022) conducted an observational in Cardiac tumors (n=55). Surgical treatment was evaluated on Mortality. Surgical treatment of benign cardiac tumors was successful with no relapses, while malignant tumors had a poor prognosis with an overall mortality of 27% over a median 44 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: